Sodium Disorders

Introduction to Sodium

  • Normal Range: The normal serum sodium level is between 135145 mEq/L135-145 \text{ mEq/L}.

  • Primary Functions: Sodium plays crucial roles in the body, including:

    • Nerve impulse transmission.

    • Muscle contraction.

    • Maintaining acid-base balance.

    • Regulating fluid balance.

Regulation of Sodium

Sodium levels are tightly regulated by several mechanisms:

  • Aldosterone: This hormone promotes the retention of sodium in the kidneys, thereby increasing overall sodium levels in the body.

  • ADH (Antidiuretic Hormone): ADH primarily controls water reabsorption in the kidneys. By regulating water reabsorption, it indirectly affects sodium concentration.

  • Thirst Mechanism: The body's natural thirst response prompts fluid intake, which helps to dilute or concentrate sodium levels as needed.

  • Renal Function: The kidneys are central to regulating sodium and water balance, excreting or reabsorbing sodium as required.

Measurement of Sodium Levels

Sodium levels can be measured in two primary ways:

  • Actual: Refers to the absolute amount of sodium molecules present in a given volume.

  • Relative: Refers to the concentration of sodium in relation to the overall fluid volume.

Hyponatremia

Hyponatremia is defined by a serum sodium level of less than < 135 \text{ mEq/L}.

  • Etiology (Primary Types):

    • Hypovolemic Hyponatremia: Characterized by a decrease in both total body water and total body sodium, with sodium loss being proportionally greater.

    • Euvolemic Hyponatremia: Primarily involves a decrease in total body sodium while total body water remains relatively constant, or a slight increase in water without overt edema.

    • Hypervolemic (Dilutional) Hyponatremia: Occurs when there is an increase in total body water compared to total body sodium. This leads to a dilution of sodium, even though total body sodium might be normal or even elevated; the concentration drops below 135 mEq/L135 \text{ mEq/L}.

  • Risk Factors:

    • Older Age: Elderly individuals may be at higher risk due to various factors including altered thirst sensation, medication use, and comorbidities.

    • Medications: Certain drugs, such as diuretics, can lead to increased sodium excretion.

    • Neurological Disorders: Conditions affecting the brain can disrupt ADH regulation or fluid intake.

    • Cancer: Specifically, lung cancer (small cell lung carcinoma) is a common cause of SIADH, leading to hyponatremia.

    • Surgery: Post-operative states can contribute to hyponatremia due to fluid administration, pain, nausea, and stress-induced ADH release.

  • Pathophysiology ("Blows up the cell"):

    • A low serum sodium concentration leads to a decreased serum osmolality.

    • This osmotic imbalance causes water to shift from the Extracellular Fluid (ECF) into the Intracellular Fluid (ICF).

    • The influx of water into cells results in cellular swelling.

  • Clinical Manifestations: Symptoms vary based on severity and the rate of onset:

    • Mild: Fatigue.

    • Moderate: Confusion.

    • Severe: Seizures, coma.

  • Complications:

    • Cerebral Edema: Swelling of brain cells due to water shifting into the cells, which can be life-threatening.

    • Seizures: A direct consequence of cerebral edema and neuronal dysfunction.

    • Brain Damage: Permanent neurological impairment can occur if cerebral edema is severe or prolonged.

Exemplar Disease: SIADH (Syndrome of Inappropriate Antidiuretic Hormone Secretion)
  • Definition: SIADH is characterized by excessive secretion of ADH, leading to inappropriate water retention by the kidneys, which results in dilutional hyponatremia.

  • Causes of SIADH:

    • Neurological Injuries: Conditions like stroke, hemorrhage, or trauma to the head can disrupt ADH regulation.

    • Lung Disease: Various pulmonary conditions can stimulate ADH release.

    • Cancer: Particularly small cell lung carcinoma, acts as an ectopic source of ADH.

    • Medications: Certain drugs (e.g., antidepressants, antipsychotics, some chemotherapy agents) can induce SIADH.

  • SIADH Key Features:

    • Increased Sodium in Urine: Despite low serum sodium, the urine osmolarity is inappropriately high, indicating the kidneys are retaining water but not excreting dilute urine. This leads to increased urine sodium concentration.

  • SIADH General Treatment:

    • Restrict Fluid Intake: This is a primary treatment to reduce water overload and slowly correct hyponatremia.

    • Highly Concentrated IV Fluids: Hypertonic saline (3\text{%} NaCl) may be used cautiously in severe, symptomatic hyponatremia to rapidly increase serum sodium.

    • ADH Blockers (Vaptans): Medications like tolvaptan can block the action of ADH at the renal tubules, promoting water excretion.

Hypernatremia

Hypernatremia is defined by a serum sodium level greater than > 145 \text{ mEq/L}.

  • Etiology (Primary Reasons):

    • Water Loss > Sodium Loss (Relative): This occurs when more water is lost from the body than sodium, leading to a concentrated state where the remaining sodium becomes hypertonic. Examples include:

      • Diabetes Insipidus: Inability to concentrate urine, leading to significant free water loss.

      • Excessive Sweating: Significant loss of hypotonic fluid through sweat.

      • Elevated Blood Sugar: Hyperglycemia can cause osmotic diuresis, leading to free water loss.

    • Excess Sodium Intake (Actual): Direct ingestion or administration of too much sodium. Examples include:

      • Highly Concentrated IV Fluids (Hypertonic Fluids): Administration of hypertonic saline or other hypertonic solutions.

      • Excess Salt Ingestion: Ingesting large amounts of salt without adequate water intake.

  • Risk Factors:

    • Older Age: Elderly individuals may have a blunted thirst response or reduced access to fluids.

    • Limited Access to Water: Incapacitated individuals or those without easy access to water are at higher risk.

    • Medications: Certain drugs (e.g., lithium) can impair thirst or increase water loss.

  • Pathophysiology ("Cell Shrinks"):

    • An increased serum sodium concentration leads to increased serum osmolality.

    • This osmotic gradient causes water to move from the Intracellular Fluid (ICF) to the Extracellular Fluid (ECF).

    • The outflow of water from cells results in cellular dehydration and shrinkage.

  • Clinical Manifestations:

    • Mild: Thirst (a prominent symptom), dry mucous membranes.

    • Moderate: Irritability, restlessness, weakness.

    • Severe: Coma, seizures as a result of brain cell shrinkage.

  • Complications:

    • Intracerebral Hemorrhage: Severe brain cell shrinkage can pull on and damage blood vessels in the brain, leading to bleeding.

    • Coma: Due to severe neurological dysfunction.

    • Death: If hypernatremia is severe and uncorrected.

Exemplar Disease: Diabetes Insipidus (DI)
  • Definition: Diabetes Insipidus is a disorder characterized by the inability to concentrate urine, leading to excessive excretion of dilute urine (free water loss without significant electrolyte loss), which can result in hypernatremia. The kidney's inability to reabsorb water leads to a decreased urine osmolality, while serum osmolality increases.

  • Types of Diabetes Insipidus (at risk for hypovolemia):

    • Central DI: Caused by decreased production or release of ADH from the posterior pituitary gland.

    • Nephrogenic DI: Occurs when the kidneys are unable to respond properly to ADH, even if ADH production is normal.

  • Causes of Diabetes Insipidus:

    • Neurosurgery: Procedures involving the brain or pituitary gland.

    • Head Trauma: Damage to the hypothalamus or pituitary.

    • Brain Tumors: Lesions in or near the ADH-producing or releasing areas.

    • Medications: Certain drugs (e.g., lithium) can cause nephrogenic DI.

  • Diabetes Insipidus Key Features:

    • High Serum Sodium: Reflects the overall dehydration and concentrated intravascular space.

    • Low Urine Osmolality: Indicates the kidneys are passing out very dilute urine because they cannot reabsorb water.

  • Diabetes Insipidus General Treatment:

    • Synthetic ADH (Desmopressin): For Central DI, desmopressin replaces the missing ADH.

    • Low Sodium Diet: May be recommended for Nephrogenic DI to help reduce urine volume.

    • Adequate Hydration: Crucial to prevent dehydration and hypernatremia, particularly for patients who can drink fluids.

Overview of Sodium Disorders: Comparative Table

Feature

Hyponatremia

Hypernatremia

Serum Sodium

< 135 \text{ mEq/L}

> 145 \text{ mEq/L}

Osmolality

Decreased or normal

Increased

Common Causes

Diuretics, heart failure

Dehydration, salt overload

Risk Factors

Older age, neurological disorders, cancer, surgery, medications

Older age, limited access to water, medications, diabetes insipidus

Key Features

Fatigue, headache, confusion, seizures

Thirst, irritability, confusion, seizures, coma

Treatment

Fluid restriction, hypertonic saline, ADH blockers

Fluid resuscitation (hypotonic fluids), synthetic ADH (for Central DI)

Complications

Cerebral edema, seizures, brain damage

Brain shrinkage, intracerebral hemorrhage, coma, death

Exemplar Disease

SIADH

Diabetes Insipidus